Axsome Therapeutics
Price & Volume
Stats
See more52W Range | $75.56-$139.13 |
Market Cap | $5.8B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $495M |
Revenue Growth (YoY) | 72.1% |
Gross Profit (12 Mos) | $452.8M |
Diluted EPS | -$5.06 |
News
See moreYahoo Finance • 5 days ago
How Investors May Respond To Axsome Therapeutics (AXSM) Showcasing Late-Stage CNS Pipeline Data at Psych Congress
Yahoo Finance • 8 days ago
Axsome Therapeutics Highlights Data Across Its Leading Neuroscience Pipeline at Psych Congress 2025
Yahoo Finance • 13 days ago
Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss — Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm
Yahoo Finance • 29 days ago
Axsome Therapeutics to Participate in Upcoming Investor Conferences
About
CEO | Dr. Herriot Tabuteau M.D. |
Address | One World Trade Center, New York, NY, United States, 10007 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 846 |
